Finance

Lists
002287:SHE
Tibet Cheezheng Tibetan Medicine Co Ltd
19,16 CNY
-0,21%
(-0,040) 1D
16 ოქტ, 15:04:06 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002287...
Open
19,27 CNY
High
19,64 CNY
Low
19,01 CNY
Mkt. cap
11,08 მლრდ.
Avg. vol.
1,30 მლნ.
Volume
2,06 მლნ.
Dividend
3,34%
Quarterly dividend
0,16 CNY
Ex-dividend date
23 სექ. 2026
P/E ratio
16,36
52-wk high
27,33 CNY
52-wk low
18,33 CNY
EPS
1,17 CNY
Shares outstanding
572,12 მლნ.
No. of employees
3 ათ.
Open
19,27 CNY
High
19,64 CNY
Low
19,01 CNY
Mkt. cap
11,08 მლრდ.
Avg. vol.
1,30 მლნ.
Volume
2,06 მლნ.
Dividend
3,34%
Quarterly dividend
0,16 CNY
Ex-dividend date
23 სექ. 2026
P/E ratio
16,36
52-wk high
27,33 CNY
52-wk low
18,33 CNY
EPS
1,17 CNY
Shares outstanding
572,12 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Fierce Biotech
Fierce Biotech
·
1 საათის წინ
City goes public with $200M IPO, while Frazier Life Sciences takes biotech-focused SPAC to Nasdaq
Altcoin Buzz
Altcoin Buzz
·
29 წუთის წინ
Garlinghouse Rings Nasdaq Bell as Evernorth Deploys 473M XRP
TradingView
TradingView
·
1 საათის წინ
Key facts: NASDAQ:ASTS delayed 2027; Piper Sandler Neutral; $1B note
Investor's Business Daily
Investor's Business Daily
·
5 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
Profile
Tibet Cheezheng Tibetan Medicine, or Tibet Qizheng Tibetan Medicine Co., Ltd is a prominent firm in the Tibetan medicine sector in China, primarily focused on the research, development, manufacture, and sales of Tibetan medicinal products. Wikipedia
About Tibet Cheezheng Tibetan Medicine Co Ltd
CEO-
Employees3,2 ათ.
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitecheezheng.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
347,89 მლნ.
893,07 მლნ.
405,25 მლნ.
572,72 მლნ.
Cost of goods sold
61,48 მლნ.
140,40 მლნ.
65,12 მლნ.
115,25 მლნ.
Cost of revenue
61,48 მლნ.
140,40 მლნ.
65,12 მლნ.
115,25 მლნ.
Research and development expenses
17,52 მლნ.
31,37 მლნ.
14,95 მლნ.
17,97 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264,43 მლნ.
467,36 მლნ.
231,41 მლნ.
178,28 მლნ.
Operating expense
287,80 მლნ.
506,73 მლნ.
250,16 მლნ.
208,55 მლნ.
Total operating expenses
349,28 მლნ.
647,13 მლნ.
315,28 მლნ.
323,80 მლნ.
Operating income
-1,40 მლნ.
245,94 მლნ.
89,97 მლნ.
248,92 მლნ.
Other non operating income
269,69 ათ.
-863,06 ათ.
462,08 ათ.
169,34 ათ.
EBT including unusual items
69,67 მლნ.
267,60 მლნ.
109,04 მლნ.
305,43 მლნ.
EBT excluding unusual items
-8,28 მლნ.
245,93 მლნ.
90,15 მლნ.
249,46 მლნ.
Income tax expense
5,56 მლნ.
43,69 მლნ.
15,07 მლნ.
29,25 მლნ.
Effective tax rate
7,98%
16,33%
13,82%
9,58%
Other operating expenses
4,85 მლნ.
9,39 მლნ.
3,92 მლნ.
11,87 მლნ.
Net income
65,12 მლნ.
224,91 მლნ.
95,18 მლნ.
276,12 მლნ.
Net profit margin
18,72%
25,18%
23,49%
48,21%
Earnings per share
-
-
-
-
Interest and investment income
1,78 მლნ.
3,52 მლნ.
1,77 მლნ.
1,74 მლნ.
Interest expense
-9,89 მლნ.
-2,55 მლნ.
-2,05 მლნ.
-1,81 მლნ.
Net interest expenses
-8,11 მლნ.
978,68 ათ.
-280,98 ათ.
-63,34 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
25,60 მლნ.
279,82 მლნ.
123,85 მლნ.
283,96 მლნ.
Gain or loss from assets sale
909,31 ათ.
-7,38 მლნ.
-
-248,14 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები